Eddie Eltoukhy
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
Eddie Eltoukhy is a Venture Partner at Pear VC, where he leads the firm’s investments in companies specializing in life sciences. He trained in biological engineering at MIT, where his doctoral studies focused on non-viral gene therapies, and later worked as a scientist on formulation and process scale-up for ocular drug products that are now FDA-approved. He then held roles and internships spanning Roche/Genentech, NanoDimension, and Senti Bio, where he served as Head of Corporate Development. He is known for work at the intersection of biotechnology science, business, and the commercial and clinical translation of life sciences technologies.
Updated 8 September 2026
Public sources: pear.vc
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Eddie Eltoukhy appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data